Volume 27, Issue 2 pp. 97-100
Therapeutic Hotline

Frictional purpuric eruption associated with angiotensin II receptor blockers

Caterina Foti

Corresponding Author

Caterina Foti

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy

Address correspondence and reprint requests to: Caterina Foti, Associate Professor, Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, 70124 Bari, Italy, or email: [email protected].Search for more papers by this author
Anna Maria Carbonara

Anna Maria Carbonara

Dermatology Department, Di Venere Hospital, Bari-Carbonara, Italy

Search for more papers by this author
Stefania Guida

Stefania Guida

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy

Search for more papers by this author
Annarita Antelmi

Annarita Antelmi

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy

Search for more papers by this author
Antonio Mazzocca

Antonio Mazzocca

Department of Emergency and Organ Transplantation, Section of Internal Medicine, Allergology and Clinical Immunology, University of Bari Medical School, Bari, Italy

Search for more papers by this author
Paolo Romita

Paolo Romita

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy

Search for more papers by this author
Domenico Bonamonte

Domenico Bonamonte

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy

Search for more papers by this author
Giovanni Angelini

Giovanni Angelini

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy

Search for more papers by this author
First published: 21 May 2013
Citations: 4
Conflict of interest: None.
Financial support: None.

Abstract

Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. There are few reports about cutaneous side effects of ARBs. The present authors describe herein four cases of purpuric eruption mainly involving sites of friction in patients taking ARBs. These eruptions completely cleared after stopping the drug and implementing preservative measures to reduce friction.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.